| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020152 |
| Receipt No. | R000023278 |
| Official scientific title of the study | The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients. |
| Date of disclosure of the study information | 2015/12/15 |
| Last modified on | 2018/11/07 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients. | |
| Title of the study (Brief title) | The effects of royal jelly for the adverse events of molecular target therapy for renal cancer patients. | |
| Region |
|
|
| Condition | ||
| Condition | Renal cell carcinoma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Some molecular target therapies are effctive for the renal cell carcinoma. However, some patients are suffering from adverse events,stomatitis, hypertension, and hand-foot syndrome. The mainly aim for this study is to examine the preventive effects of royal jelly for the adverse events of the molecular target therapies. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The efficacy of royal jelly for the skin problem of the molecular target therapy. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | We examine this research using double-blind method. We divide the patients into two groups, royal jelly group and placebo-control group.The group of royal jelly patients take 2400mg /day royal jelly for 90 days. | |
| Interventions/Control_2 | The patients of placebo group take encapsulated drugs 3 times a day for 90 days | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. renal cell carcinoma patient
2. performance status 0-1 3. WBC 3000/mm3 <= Neutro:1500/mm3 <= PLT:100,000/mm3 <= Hb:8g/dl <= AST and ALT:Upper limit 3 times or less T.Bil:1.5mg/dl => Crea:2.0mg/dl => FB:125mg/dl => 4. Those who can start this research within two weeks after resistration. 5. those who are 20 years and older 6. those who allow the participation for this study |
|||
| Key exclusion criteria | 1. those who have possibility of the cancer death within six months
2.those who have allergy for honey 3. those who have some allergy for foods and drugs 4. those who have another cancer |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuyoshi Miyata |
| Organization | Nagasaki University Hospital |
| Division name | Urology and Renal transplantation |
| Address | 1-7-1,Samkamoto, Nagasaki, Japan |
| TEL | 095-819-7340 |
| int.doc.miya@m3.dion.ne.jp | |
| Public contact | |
| Name of contact person | Tomohiro Matsuo |
| Organization | Nagasaki University Hospital |
| Division name | Urology and Renal transplantation |
| Address | 1-7-1,Samkamoto, Nagasaki, Japan |
| TEL | 095-819-7340 |
| Homepage URL | |
| tomo1228@nagasaki-u.ac.jp | |
| Sponsor | |
| Institute | Department of Urology and Renal transplantation, Nagasaki University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yamada Research Grant |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023278 |